NeoGenomics Inc. (NEO)
NASDAQ: NEO
· Real-Time Price · USD
6.27
0.03 (0.48%)
At close: Aug 19, 2025, 10:19 AM
0.48% (1D)
| Bid | n/a |
| Market Cap | 159.72M |
| Revenue (ttm) | 689.19M |
| Net Income (ttm) | -104.04M |
| EPS (ttm) | -0.82 |
| PE Ratio (ttm) | -7.65 |
| Forward PE | 32.19 |
| Analyst | Hold |
| Ask | n/a |
| Volume | 120,096 |
| Avg. Volume (20D) | 2,238,462 |
| Open | 6.27 |
| Previous Close | 6.24 |
| Day's Range | 6.22 - 6.29 |
| 52-Week Range | 4.72 - 19.11 |
| Beta | 1.54 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NEO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
NeoGenomics Inc. is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-18.73%
NeoGenomics shares are trading lower after the com...
Unlock content with
Pro Subscription
3 months ago
-2.74%
NeoGenomics shares are trading lower after Leerink Partners downgraded the stock from Outperform to Market Perform and lowered its price target from $25 to $9.
